Editorial response: Hyperlactatemia and hepatic steatosis as features of mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors

Authors
Brinkman, K
Citation
K. Brinkman, Editorial response: Hyperlactatemia and hepatic steatosis as features of mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors, CLIN INF D, 31(1), 2000, pp. 167-169
Citations number
13
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
CLINICAL INFECTIOUS DISEASES
ISSN journal
10584838 → ACNP
Volume
31
Issue
1
Year of publication
2000
Pages
167 - 169
Database
ISI
SICI code
1058-4838(200007)31:1<167:ERHAHS>2.0.ZU;2-S